Acupuncture for Sleep Disorders: Newer Clinical Evidence on Dose, Mechanisms, and How It Compares With CBT-I

Patient receiving acupuncture in a calm, earth-toned treatment room with soft natural light

article-type: evidence review
target-keyword: acupuncture for sleep disorders
evidence-cutoff: 2026-09-18
scope: comparative effectiveness / dose-response / mechanisms / population-specific evidence

Acupuncture for sleep disorders is supported by newer comparative and mechanistic research, but its clinical role requires distinction between acupuncture, cognitive behavioral therapy for insomnia (CBT-I), hypnotic medication, and supportive care for secondary insomnia.

The current evidence indicates:

  • acupuncture produces clinically relevant improvements in subjective insomnia outcomes;
  • treatment effects appear stronger with repeated, course-based treatment rather than isolated sessions;
  • CBT-I remains first-line treatment for chronic insomnia;
  • acupuncture may function as an adjunct or alternative when CBT-I is unavailable, unsuitable, or not accepted;
  • evidence for objective sleep changes, long-term relapse prevention, and biological mechanisms remains less certain.

2026 network meta-analysis: modality rankings for primary insomnia

A systematic review and Bayesian network meta-analysis published in Frontiers in Neurology in March 2026 evaluated 80 randomized trials involving 7,791 patients with primary insomnia.1

The analysis compared conventional acupuncture, abdominal acupuncture, electroacupuncture, catgut embedding, warm acupuncture, scalp acupuncture, press needle, wrist-ankle acupuncture, fire needle, sham acupuncture, and conventional medication.

The reported findings included:

  • abdominal acupuncture reduced PSQI scores compared with conventional medication in short-term treatment;
  • conventional acupuncture and catgut embedding also reduced PSQI scores compared with medication;
  • abdominal acupuncture ranked highest for short-term and longer-term PSQI outcomes using SUCRA rankings;
  • warm acupuncture demonstrated a favorable long-term comparison with conventional acupuncture;
  • electroacupuncture ranked relatively high for reported clinical efficacy rates;
  • catgut embedding ranked highly for some depression and traditional Chinese medicine syndrome outcomes;
  • no single modality ranked first across every outcome;
  • adverse-event reporting was incomplete, and no acupuncture method demonstrated clear superiority for safety.

The authors reported substantial methodological heterogeneity, including differences in acupoint selection, session frequency, needle retention, follow-up, and control medication. The rankings therefore identify statistical patterns rather than a universally optimal protocol.

2025 Bayesian network meta-analysis: acupuncture versus hypnotic medication

A 2025 Bayesian network meta-analysis in Integrative Medicine Research included 64 randomized trials and 4,443 participants with primary insomnia.2

For PSQI outcomes, the ranking was:

  • acupuncture combined with moxibustion;
  • acupuncture combined with auriculotherapy;
  • electroacupuncture;
  • moxibustion;
  • acupuncture combined with bloodletting therapy;
  • auriculotherapy;
  • conventional acupuncture;
  • catgut embedding;
  • intradermal needling;
  • zolpidem, alprazolam, and estazolam.

For clinical effectiveness rates, catgut embedding ranked highest, followed by acupuncture combined with moxibustion, acupuncture combined with auriculotherapy, electroacupuncture, and conventional acupuncture.

The review concluded that several acupuncture-based interventions performed better than commonly used hypnotics on selected outcomes. The certainty of evidence remained limited because most trials were small, treatment courses were short, follow-up was inconsistent, and the overall risk of bias was substantial.

bottom-line: network meta-analyses identify promising acupuncture modalities, but ranking does not establish treatment equivalence, long-term superiority, or replacement of CBT-I.

Practitioner and patient reviewing a sleep diary during a consultation

Head-to-head comparison: acupuncture and CBT-I in cancer survivors

A randomized clinical trial published in the Journal of the National Cancer Institute in 2019 directly compared acupuncture with CBT-I in cancer survivors with insomnia.3

Participants received eight weeks of acupuncture or CBT-I and were followed through week 20. Both interventions produced clinically meaningful reductions in insomnia severity:

  • CBT-I reduced ISI scores by approximately 10.9 points;
  • acupuncture reduced ISI scores by approximately 8.3 points;
  • the between-group difference favored CBT-I by approximately 2.6 points;
  • both treatment effects remained durable during follow-up.

The trial did not support acupuncture as superior to CBT-I. CBT-I performed better overall and remains the first-line behavioral treatment for chronic insomnia according to clinical practice guidelines.4

Acupuncture remains clinically relevant in cancer supportive care when:

  • CBT-I access is limited;
  • a patient cannot participate in structured behavioral treatment;
  • insomnia occurs with pain, anxiety, treatment-related symptoms, or musculoskeletal tension;
  • acupuncture is used alongside, rather than instead of, oncology care or CBT-I.

The trial’s cancer-survivor population is particularly relevant to patients experiencing persistent sleep disruption after chemotherapy, radiation, surgery, hormonal therapy, or prolonged anxiety.

Population-specific evidence

Perimenopausal insomnia

A 2025 systematic review and meta-analysis in Frontiers in Medicine included 12 trials and 994 perimenopausal participants.5

Compared with drug controls, acupuncture reduced PSQI scores by a pooled mean difference of approximately −2.26 points. Comparisons favored acupuncture over estazolam, although results varied by medication. Acupuncture also produced changes in follicle-stimulating hormone, luteinizing hormone, and estradiol in a limited number of trials.

A 2021 systematic review comparing acupuncture with Western medication reported comparable or favorable sleep outcomes for acupuncture in perimenopausal insomnia.6

The evidence is relevant to sleep disruption associated with:

  • hot flashes and night sweats;
  • anxiety and mood changes;
  • altered menstrual patterns;
  • temperature dysregulation;
  • fatigue and daytime cognitive symptoms.

The 2025 review rated the evidence as low to moderate quality. Adverse-event reporting was incomplete.

Cancer-related insomnia

A 2024 network meta-analysis of acupuncture-related interventions for cancer-related insomnia evaluated 37 randomized trials and approximately 3,246 participants.7

Auriculotherapy combined with moxibustion ranked highly for sleep outcomes, with auriculotherapy and electroacupuncture also showing favorable results in selected comparisons. The analysis reported improvement in insomnia severity and sleep quality compared with usual care, medication, or sham interventions.

The cancer-related evidence remains fragmented by:

  • cancer type;
  • treatment status;
  • pain and fatigue burden;
  • medication exposure;
  • use of auriculotherapy, electroacupuncture, acupressure, or manual acupuncture;
  • inconsistent follow-up periods.

Acupuncture should be coordinated with the oncology team. It does not replace cancer treatment, medication management, sleep-apnea evaluation, or psychological care.

Dose-response: frequency, sessions, retention, and course duration

A 2025 dose-effect meta-analysis in Frontiers in Psychiatry assessed treatment intensity for primary insomnia.8

The reported dose pattern included:

  • total sessions: greater effects with 12 or more sessions;
  • frequency: approximately three sessions per week;
  • course duration: approximately three to four weeks;
  • needle retention: commonly 20–30 minutes per session in the underlying trials;
  • lower exposure: 10 or fewer sessions and courses of two weeks or less were less consistently effective;
  • higher exposure: five to seven sessions per week could be effective but did not consistently outperform three sessions per week;
  • extended courses: treatment beyond four weeks did not consistently produce additional PSQI improvement.

The evidence supports a course-based model rather than a single-session expectation. A frequently studied schedule is approximately 12 sessions over four weeks, with reassessment based on sleep diary data, daytime function, symptom trajectory, and treatment tolerance.

Dose-response findings should not be interpreted as a fixed prescription. Patient age, comorbid pain, medication use, menopause status, cancer history, anxiety, and sleep-disorder subtype influence treatment planning.

Close-up still life of acupuncture needles beside a handwritten sleep log

Proposed mechanisms: GABA, autonomic regulation, HPA-axis activity, and inflammation

A 2024 review in Frontiers in Neurology described central regulatory pathways potentially involved in acupuncture for primary insomnia.9

A 2026 review in Frontiers in Neuroscience further framed acupuncture as a possible neuromodulatory intervention affecting sleep-wake circuitry.10

The mechanisms remain proposed rather than definitively established in humans.

GABAergic and glutamatergic signaling

Preclinical research indicates that acupuncture may:

  • increase central gamma-aminobutyric acid, or GABA;
  • increase GABA-A receptor expression in relevant sleep-regulatory regions;
  • reduce excessive glutamatergic excitation;
  • lower the glutamate-to-GABA imbalance associated with hyperarousal;
  • influence the thalamic reticular nucleus and thalamocortical sleep gating.

Human studies have reported changes in serum or central neurotransmitter markers, but biomarker findings do not yet establish that GABA-A modulation directly causes clinical sleep improvement.

Autonomic balance

Insomnia frequently includes increased sympathetic activity and reduced parasympathetic regulation. Acupuncture research has examined:

  • heart-rate variability;
  • sympathetic arousal;
  • vagal activity;
  • stress-related physiological activation.

The proposed effect is reduced sympathetic predominance with improved vagal tone. This mechanism may be relevant when insomnia occurs with anxiety, chronic pain, muscle tension, or persistent stress.

HPA-axis and endocrine regulation

Studies have associated acupuncture treatment with:

  • lower cortisol levels;
  • altered cortisol rhythm;
  • increased melatonin in selected populations;
  • changes in hypothalamic-pituitary-adrenal axis activity.

These findings provide a possible explanation for sleep changes occurring alongside anxiety, menopause-related symptoms, or prolonged inflammatory stress.

Neuroinflammation and microbiota-gut-brain signaling

Recent mechanistic reviews describe interactions among:

  • inflammatory cytokines;
  • microglial activation;
  • vagal signaling;
  • intestinal microbiota;
  • GABA and glutamate metabolism;
  • HPA-axis activity.

Electroacupuncture and related interventions have been studied for their potential to influence the microbiota-gut-brain axis, including GABA-producing bacterial populations and inflammatory signaling. Much of this evidence remains preclinical or based on small translational studies.

Safety, limitations, and sleep-medicine assessment

Acupuncture is generally associated with mild, transient adverse events when delivered by a properly trained practitioner. Reported events include:

  • localized bruising or bleeding;
  • temporary soreness;
  • dizziness or fainting;
  • short-term pain at the needle site;
  • headache;
  • fatigue.

Safety data are limited by inconsistent adverse-event reporting. Patients should disclose anticoagulant use, bleeding disorders, pregnancy, implanted devices, infection risk, cancer treatment, and all medications or supplements.

Sleep-medicine assessment is indicated when symptoms suggest:

  • obstructive sleep apnea: loud snoring, witnessed apneas, gasping, morning headaches, resistant hypertension, or excessive daytime sleepiness;
  • restless legs syndrome: an urge to move the legs with uncomfortable sensations that worsen at rest or at night;
  • parasomnias: sleepwalking, dream enactment, recurrent night terrors, or injurious nighttime behavior;
  • narcolepsy, circadian rhythm disorders, severe depression, mania, or medication-related sleep disruption.

Acupuncture should not delay diagnostic evaluation for these conditions.

EnerQi individualized root-cause assessment

EnerQi Wellness uses acupuncture and Chinese medicine to review sleep in relation to history, stress load, pain, movement, lifestyle, digestion, hormonal changes, and symptom patterns.

Relevant internal resources:

The Root Cause Discovery Call is a 15-minute initial assessment used to review the primary concern, relevant history, and appropriate care pathway. Acupuncture may be considered as part of individualized care, with CBT-I, sleep-medicine evaluation, oncology coordination, and conventional medical treatment retained when clinically indicated.

References

  1. Fang T, Cao X, Liu L, Lu S. Comparative effectiveness and safety of acupuncture treatments for primary insomnia: a systematic review and network meta-analysis of randomized trial. Frontiers in Neurology. 2026. https://doi.org/10.3389/fneur.2026.1750474

  2. Liu L, Chen Y, Tian M, et al. The efficacy and safety of multiple acupuncture therapies in primary insomnia: a Bayesian network meta-analysis. Integrative Medicine Research. 2025;14(4):101206. https://pmc.ncbi.nlm.nih.gov/articles/PMC12454287/

  3. Garland SN, et al. Acupuncture versus cognitive behavioral therapy for insomnia in cancer survivors: a randomized clinical trial. Journal of the National Cancer Institute. 2019. https://pubmed.ncbi.nlm.nih.gov/31081899/

  4. Edinger JD, et al. Behavioral and psychological treatments for chronic insomnia disorder in adults. Journal of Clinical Sleep Medicine. 2021. https://pubmed.ncbi.nlm.nih.gov/33164742/

  5. Yang R, et al. Acupuncture for perimenopausal insomnia: a systematic review and meta-analysis. Frontiers in Medicine. 2025;12:1673994. https://doi.org/10.3389/fmed.2025.1673994

  6. Zhao F, et al. Comparative utility of acupuncture and Western medication in the management of perimenopausal insomnia. Evidence-Based Complementary and Alternative Medicine. 2021. https://pubmed.ncbi.nlm.nih.gov/33986818/

  7. 2024 network meta-analysis of acupuncture-related interventions for cancer-related insomnia. PubMed record: https://pubmed.ncbi.nlm.nih.gov/39384192/

  8. Zhang X, et al. The dose-effect relationship between acupuncture and its effect on primary insomnia: a systematic review and meta-analysis. Frontiers in Psychiatry. 2025;16:1501321. https://pubmed.ncbi.nlm.nih.gov/39995954/

  9. Yao L, et al. The central regulatory effects of acupuncture in treating primary insomnia: a review. Frontiers in Neurology. 2024;15:1406485. https://pmc.ncbi.nlm.nih.gov/articles/PMC11666528/

  10. Ming J, et al. Acupuncture and sleep-wake regulation: a neuromodulatory perspective. Frontiers in Neuroscience. 2026. https://www.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2026.1884710/full